Amedisys (AMED) Tops Q2 EPS by 28c
Tweet
Share
E-mail
Get Alerts AMED Hot Sheet
Price: $100.99 --0%
Financial Fact:
Non-cash compensation: 4.75M
Today's EPS Names:
MAYS, CRMT, REPL, More
Financial Fact:
Non-cash compensation: 4.75M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Amedisys (NASDAQ: AMED) reported Q2 EPS of $1.37, $0.28 better than the analyst estimate of $1.09. Revenue for the quarter came in at $552.97 million versus the consensus estimate of $568.18 million.
For earnings history and earnings-related data on Amedisys (AMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- Ares Management, L.P. (ARES) PT Raised to $153 at TD Cowen
- Morgan Stanley Starts Adani Enterprises Ltd. (ADE:IN) at Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
